cse: ORIG*

There’s a bright future in

psychedelic therapeutic treatments.

Supported by science, we see the opportunity to support innovators as they bring these new psychedelic treatments to market.

*Proposed stock ticker.

Stay Updated

By subscribing, you agree to receive emails from Origin. You may choose to unsubscribe at any time

A Global Psychedelic-Focused Investment Opportunity

Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry.

Our Approach

A robust strategy guided by HEAL principles.

H

Human-Focused

The industry developing now has the potential for more than just profitable investments: it’s a way to further treatment in mental health. We’re investing in a diverse portfolio with one commonality: the betterment of all of us.

E

Expertise

Knowing the market, is winning the market. Our in-house expertise and relationships with industry specialists allows us to make decisions from a position of strength.

A

Access

Brokering partnerships with key players gives us VIP access to exclusive opportunities not available to the public.

L

Leadership

The most important asset we have is our team. This powerhouse group brings the insight, analysis, and executive skill backed by decades of successful multi-billion dollar projects.

Our Investment Strategy

We focus on companies with an exemplary management team and exponential growth profile.